🇺🇸 FDA
Patent

US 6946247

RNAse probe protection assays in screening for modulators of immunoglobulin germline transcription

expired A61KA61K2039/505

Quick answer

US patent 6946247 (RNAse probe protection assays in screening for modulators of immunoglobulin germline transcription) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505